We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 3 for:    inovation
Previous Study | Return to List | Next Study

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH (INOvation-1)

This study is currently recruiting participants.
Verified August 2017 by Bellerophon ( Bellerophon Pulse Technologies )
Sponsor:
ClinicalTrials.gov Identifier:
NCT02725372
First Posted: April 1, 2016
Last Update Posted: August 17, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
Worldwide Clinical Trials
Information provided by (Responsible Party):
Bellerophon ( Bellerophon Pulse Technologies )
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: July 2018 (Final data collection date for primary outcome measure)